No added benefit of dimethyl fumarate for multiple sclerosis can be determined, as no suitable data are available, neither for a direct nor for an indirect comparison, report researchers. Dimethyl ...

Please provide your email address to receive an email when new articles are posted on . BOSTON — Women with MS who were exposed to dimethyl fumarate in the first trimester had no unexpected adverse ...

VANCOUVER — Fingolimod (Gilenya, Novartis) was better tolerated than dimethyl fumarate (Tecfidera, Biogen) in a 2-year comparison of the oral multiple sclerosis (MS) drugs. Patients receiving dimethyl ...

Treatment with dimethyl fumarate, compared with teriflunomide, is associated with better clinical outcomes in patients with relapsing-remitting multiple sclerosis (MS), according to new research. Time ...

A recent study sought to compare several available oral immunotherapies for the treatment of relapsing-remitting multiple sclerosis (MS). A recent study sought to compare several available oral ...

Discover comprehensive details about Dimethyl Fumarate, including its pronunciation, uses, dosage instructions, indications, and guidelines on how and when to take it or avoid it. The updated ...

BOUCHERVILLE, Quebec, Oct. 04, 2021 (GLOBE NEWSWIRE) -- Sandoz Canada announced today the launch of Pr Sandoz ® Dimethyl Fumarate Delayed-Release Capsules, a generic equivalent to Biogen Canada’s Pr ...

The Appraisal Committee considered evidence submitted by the manufacturer of dimethyl fumarate and a review of this submission by the Evidence Review Group (ERG). The DEFINE trial was an international ...

In a recent study posted to the medRxiv* preprint server, researchers evaluated the efficacy of the anti-inflammatory drug dimethyl fumarate (DMF) in treating coronavirus disease 2019 (COVID-19) as ...

Dimethyl fumarate (trade name: Tecfidera) has been approved since January 2014 for adults with relapsing remitting multiple sclerosis (RRMS). In an early benefit assessment pursuant to the Act on the ...